Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration route
- DOI
- 10.1177/20406207251399466
- Published
- 2025-07
- Container
- Therapeutic Advances in Hematology
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/20406207251399466,
title = {Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration route},
author = {Jonas Paludo and Lisa Nodzon and Xavier Woot de Trixhe and Michelle Pacia and Heena Mavani and Harisha Atluri and Thomas J. Huemann and Jessica Shelly and Yemin Liu and Shayna Sarosiek},
year = {2025},
journal = {Therapeutic Advances in Hematology},
doi = {10.1177/20406207251399466},
url = {https://doi.org/10.1177/20406207251399466}
}RIS
TY - JOUR TI - Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration route AU - Jonas Paludo AU - Lisa Nodzon AU - Xavier Woot de Trixhe AU - Michelle Pacia AU - Heena Mavani AU - Harisha Atluri AU - Thomas J. Huemann AU - Jessica Shelly AU - Yemin Liu AU - Shayna Sarosiek PY - 2025 JO - Therapeutic Advances in Hematology DO - 10.1177/20406207251399466 UR - https://doi.org/10.1177/20406207251399466 ER -
APA
Paludo, J., Nodzon, L., Trixhe, X. W. D., Pacia, M., Mavani, H., Atluri, H., Huemann, T. J., Shelly, J., Liu, Y., & Sarosiek, S. (2025). Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration route. Therapeutic Advances in Hematology. https://doi.org/10.1177/20406207251399466
Source records
- crossref · retrieved 2026-09-26T03:30:30.619Z